Symbol="APLS"
AssetType="Common Stock"
Name="Apellis Pharmaceuticals Inc"
Description="Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1492422"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2790310000"
EBITDA="-639102016"
PERatio="None"
PEGRatio="None"
BookValue="1.534"
DividendPerShare="0"
DividendYield="0"
EPS="-5.9"
RevenuePerShareTTM="0.711"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-1.581"
RevenueTTM="105887000"
GrossProfitTTM="69786000"
DilutedEPSTTM="-5.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.118"
AnalystTargetPrice="70.21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="51.26"
PriceToBookRatio="17.67"
EVToRevenue="42.79"
EVToEBITDA="-8.03"
Beta="1.268"
num_52WeekHigh="94.75"
num_52WeekLow="22.73"
num_50DayMovingAverage="73.86"
num_200DayMovingAverage="64.77"
SharesOutstanding="116457000"
DividendDate="None"
ExDividendDate="None"
symbol="APLS"
open="24.12"
high="25.30"
low="22.73"
price="23.96"
volume="6495425.00"
latest_trading_day="2023-08-02"
previous_close="24.22"
change="-0.26"
change_percent="-1.0735%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="13"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="87"
Volume_recent_avg="2870832"
Change_recent_avg="-0.12"
Delta_recent_avg="3.23"
Variance_recent_avg="1.61"
Change_ratio_recent_avg="-0.73"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="87"
Aroon_momentum_negative="13"
image_negative_thumbnail_id_1="1093"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="698"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
